Implementation of pharmacogenetics: The University of Maryland personalized anti-platelet pharmacogenetics program

Alan R. Shuldiner, Kathleen Palmer, Ruth E. Pakyz, Tameka D. Alestock, Kristin A. Maloney, Courtney O'Neill, Shaun Bhatty, Jamie Schub, Casey Lynnette Overby, Richard B. Horenstein, Toni I. Pollin, Mark D. Kelemen, Amber L. Beitelshees, Shawn W. Robinson, Miriam G. Blitzer, Patrick F. Mcardle, Lawrence Brown, Linda Jo Bone Jeng, Richard Y. Zhao, Nicholas AmbulosMark R. Vesely

Research output: Contribution to journalArticle

Abstract

Despite a substantial evidence base, implementation of pharmacogenetics into routine patient care has been slow due to a number of non-trivial practical barriers. We implemented a Personalized Anti-platelet Pharmacogenetics Program (PAP3) for cardiac catheterization patients at the University of Maryland Medical Center and the Baltimore Veterans Administration Medical Center Patients' are offered CYP2C19 genetic testing, which is performed in our Clinical Laboratory Improvement Amendment (CLIA)-certified Translational Genomics Laboratory. Results are returned within 5hr along with clinical decision support that includes interpretation of results and prescribing recommendations for anti-platelet therapy based on the Clinical Pharmacogenetics Implementation Consortium guidelines. Now with a working template for PAP3, implementation of other drug-gene pairs is in process. Lessons learned as described in this article may prove useful to other medical centers as they implement pharmacogenetics into patient care, a critical step in the pathway to personalized and genomic medicine.

Original languageEnglish (US)
Pages (from-to)76-84
Number of pages9
JournalAmerican Journal of Medical Genetics, Part C: Seminars in Medical Genetics
Volume166
Issue number1
DOIs
StatePublished - Mar 2014
Externally publishedYes

Keywords

  • Anti-platelet pharmacogenetics
  • CYP2C19
  • Clopidogrel
  • Implementation science
  • Individualized medicine
  • Personalized medicine
  • Pharmacogenomics
  • Translational research

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Implementation of pharmacogenetics: The University of Maryland personalized anti-platelet pharmacogenetics program'. Together they form a unique fingerprint.

  • Cite this

    Shuldiner, A. R., Palmer, K., Pakyz, R. E., Alestock, T. D., Maloney, K. A., O'Neill, C., Bhatty, S., Schub, J., Overby, C. L., Horenstein, R. B., Pollin, T. I., Kelemen, M. D., Beitelshees, A. L., Robinson, S. W., Blitzer, M. G., Mcardle, P. F., Brown, L., Jeng, L. J. B., Zhao, R. Y., ... Vesely, M. R. (2014). Implementation of pharmacogenetics: The University of Maryland personalized anti-platelet pharmacogenetics program. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 166(1), 76-84. https://doi.org/10.1002/ajmg.c.31396